Clinical Trial

Cannabinoids and Biological Reactivity to Stress

Study acronym: COBRAS
Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
The goal of this study is to test the impact of two drugs that produce temporary stress-like symptoms, both in isolation and together, on cannabis use motivation in individuals with Cannabis Use Disorder. The main questions it will answer are: 1. How do different forms of stress affect cannabis use motivation? 2. How do different forms of stress affect the body's natural cannabinoids? Researchers will compare a placebo to both drugs in isolation, as well as together, across four separate lab visits. Participants will: 1\) Complete a clinical screening interview (by phone or in-person) and visit the lab for a medical screening, and if eligible: a) Visit the lab four times where they will: i). Take one of four drug combinations ii). Complete an interview, questionnaires, and computerized tasks iii). Have their brain activity recorded with an EEG cap iv). Provide three blood samples
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2024-05-21; most recent amendment 2025-09-10.
Status change: Not Yet Recruiting → Recruiting 2025-01-27
Trial Details
NCT Number NCT06430580
Lead Sponsor Florida State University
Collaborators: Wayne State University, National Institute on Drug Abuse (NIDA), Auburn University
Conditions Cannabis Use Disorder
Enrollment 36 participants
Start Date 2024-09-30
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-09-16